Soluble type III TGFβ receptor in diagnosis and follow-up of patients with breast cancer

被引:12
作者
Jurisic, Darko [1 ]
Erjavec, Igor [2 ]
Trkulja, Vladimir [3 ]
Dumic-Cule, Ivo [2 ]
Hadzibegovic, Irzal [4 ]
Kovacevic, Lucija [2 ]
Svagusa, Tomo [2 ]
Stanec, Zdenko [5 ]
Vukicevic, Slobodan [2 ]
Grgurevic, Lovorka [2 ]
机构
[1] Gen Hosp, Dept Surg, Slavonski Brod, Croatia
[2] Univ Zagreb, Sch Med, Ctr Translat & Clin Res, Lab Mineralized Tissues, Salata 11, HR-10000 Zagreb, Croatia
[3] Univ Zagreb, Sch Med, Dept Pharmacol, HR-10000 Zagreb, Croatia
[4] Gen Hosp, Dept Cardiol, Slavonski Brod, Croatia
[5] Univ Hosp Dubrava, Dept Plast Reconstruct & Aesthet Surg, Zagreb, Croatia
关键词
TGF; TGFrIII; betaglycan; breast cancer; biomarker; GROWTH-FACTOR-BETA; SUPPRESSES TUMORIGENICITY; MEMBRANE PROTEOGLYCAN; BETAGLYCAN; EXPRESSION; BONE; METASTASIS; INHIBITION; PATHWAY; POTENT;
D O I
10.3109/08977194.2015.1055740
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Type III transforming growth factor (TGF) receptor (TGFrIII) modulates TGF superfamily signaling. Its tumor tissue expression is downregulated in human breast cancer. We determined (indirect ELISA) plasma levels of the soluble receptor (sTGFrIII) in 47 women with breast cancer (AJCC stages 0-IIB) (cases) pre-surgery and over two months after the surgery, and in 36 healthy women (controls). Plasma sTBFrIII was lower in cases than in the controls (age-adjusted difference -29.7ng/mL, p<0.001), and discriminated between disease and health (sensitivity and specificity 100% at 16.6ng/mL). With adjustment for age, AJCC stage, lymph node involvement, HER2 and hormone receptor status, higher pre-surgery sTBFrIII was associated with better progression-free survival (HR=0.68, 95%CI 0.49-0.89, p=0.004). An increasing trend in plasma sTBFrIII was observed over 2 months after the surgery (0.6% increase/day, p<0.001), consistently across the patient subsets. Data suggest a high potential of plasma sTBFrIII as a novel diagnostic and prognostic biomarker in breast cancer.
引用
收藏
页码:200 / 209
页数:10
相关论文
共 50 条
[41]   Recognizing Pitfalls in Breast Cancer Follow-Up: A Necessity [J].
Behnam Dalfardi .
World Journal of Surgery, 2015, 39 :547-547
[42]   Optimizing follow-up after breast cancer treatment [J].
Grunfeld, Eva .
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2009, 21 (01) :92-96
[43]   Follow-up of women with early stage breast cancer [J].
Jefford M. ;
Mann G.B. ;
Nolte L. ;
Russell L. ;
Brennan M. .
Current Breast Cancer Reports, 2014, 6 (3) :183-192
[44]   Breast cancer follow-up: Literature review and discussion [J].
Sheppard, Carmel .
EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2007, 11 (04) :340-347
[45]   Patient follow-up after treatment for breast cancer [J].
Classe, J. -M. ;
Sentilhes, L. ;
Jaffre, I. ;
Mezzadri, M. ;
Lefebvre-Lacoeuille, C. ;
Dejode, M. ;
Catala, L. ;
Bordes, V. ;
Dravet, F. ;
Descamps, P. .
JOURNAL DE GYNECOLOGIE OBSTETRIQUE ET BIOLOGIE DE LA REPRODUCTION, 2010, 39 (08) :F85-F88
[46]   Plasma Levels and Diagnostic Utility of VEGF in a Three-Year Follow-Up of Patients with Breast Cancer [J].
Bedkowska, Grazyna E. ;
Gacuta, Ewa ;
Zbucka-Kretowska, Monika ;
Lawicki, Pawel ;
Szmitkowski, Maciej ;
Lemancewicz, Adam ;
Motyka, Joanna ;
Kobus, Agnieszka ;
Chorazy, Monika ;
Paniczko, Marlena ;
Lawicki, Slawomir .
JOURNAL OF CLINICAL MEDICINE, 2021, 10 (22)
[47]   A Preliminary Analysis of Circulating Tumor Microemboli from Breast Cancer Patients during Follow-Up Visits [J].
Lai, Hung-Chih ;
Huang, Hsing-Hua ;
Hao, Yun-Jie ;
Lee, Hsin-Ling ;
Wang, Chiao-Chan ;
Ling, Thai-Yen ;
Wu, Jen-Kuei ;
Tseng, Fan-Gang .
CURRENT ONCOLOGY, 2024, 31 (09) :5677-5693
[48]   Follow-up bone scan in breast cancer patients: what is the appropriate interpretation of purely rib uptake? [J].
Seo, Minjung ;
Ko, Byung Kyun ;
Tae, Soon Young ;
Koh, Su-Jin ;
Noh, Young Ju ;
Choi, Hye-Jeong ;
Bae, Kyungkyg ;
Bang, Minseo ;
Jun, Sungmin ;
Park, Seol Hoon .
NUCLEAR MEDICINE COMMUNICATIONS, 2016, 37 (12) :1318-1324
[49]   Follow-up of patients with localized breast cancer and first indicators of advanced breast cancer recurrence: A retrospective study [J].
Viot, Julien ;
Bachour, Martin ;
Meurisse, Aurelia ;
Pivot, Xavier ;
Fiteni, Frederic .
BREAST, 2017, 34 :53-57
[50]   Predictors of delayed breast reconstruction in the Netherlands: a 5-year follow-up study in stage I-III breast cancer patients [J].
van Egdom, L. S. E. ;
de Ligt, K. M. ;
de Munck, L. ;
Koppert, L. B. ;
Mureau, M. A. M. ;
Rakhorst, H. A. ;
Siesling, S. .
BREAST CANCER, 2022, 29 (02) :324-335